Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss

Medicines in development in 2009 for stomach cancer (InTextoResearch)

0 views
Skip to first unread message

SciMedWeb

unread,
Dec 15, 2009, 5:47:35 AM12/15/09
to
Medicines in development in 2009 for stomach cancer:


● Advexin (contusugene ladenovec) Phase I/II
● AMG 102 Phase I/II
● AMG 386 Phase II
● AV-951 Phase I/II
● Avastin (bevacizumab) Phase III
● CNF-2024 Phase II
● Erbitux (cetuximab) Phase III
● Herceptin (trastuzumab) Phase III
● Hycamtin (topotecan) Phase II
● IMGN-242 Phase II
● Levulan (aminolevulinic acid)
● masitinib Phase III
● OncoGel Phase II
● Oncophage (vitespen) Phase I/II
● Opaxio (paclitaxel poliglumex ) Phase I
● PN401 Phase II
● PX-12 Phase I
● retaspimycin (IPI 504) Phase III
● Sutent (sunitinib) Phase II
● TAS-102 Phase II
● Tasigna (nilotinib) Phase III
● tesetaxel Phase II
● TheraCIM (nimotuzumab) Phase II
● TNFerade Phase II
● Tykerb (lapatinib) Phase III
● Xeloda (capecitabine) Phase II
● XL-880 Phase II


InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scim...@mail.com)


0 new messages